JPMorgan Chase & Co’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $100M | Sell |
|
|||||
|
2024
Q4 | $428M | Sell |
|
|||||
|
2024
Q3 | $387M | Buy |
|
|||||
|
2024
Q2 | $235M | Buy |
|
|||||
|
2024
Q1 | $122M | Sell |
|
|||||
|
2023
Q4 | $148M | Buy |
|
|||||
|
2023
Q3 | $108M | Buy |
|
|||||
|
2023
Q2 | $125M | Buy |
|
|||||
|
2023
Q1 | $99.1M | Buy |
|
|||||
|
2022
Q4 | $79.3M | Buy |
|
|||||
|
2022
Q3 | $8.74M | Sell |
|
|||||
|
2022
Q2 | $10.8M | Buy |
|
|||||
|
2022
Q1 | $9.62M | Buy |
|
|||||
|
2021
Q4 | $7.36M | Sell |
|
|||||
|
2021
Q3 | $5.29M | Sell |
|
|||||
|
2021
Q2 | $5.88M | Sell |
|
|||||
|
2021
Q1 | $5.07M | Sell |
|
|||||
|
2020
Q4 | $5.08M | Sell |
|
|||||
|
2020
Q3 | $4.18M | Sell |
|
|||||
|
2020
Q2 | $4.27M | Buy |
|
|||||
|
2020
Q1 | $2.52M | Sell |
|
|||||
|
2019
Q4 | $13M | Buy |
|
|||||
|
2019
Q3 | $1.6M | Buy |
|
|||||
|
2019
Q2 | $2.67M | Sell |
|
|||||
|
2019
Q1 | $2.65M | Sell |
|
|||||
|
2018
Q4 | $2.84M | Buy |
|
|||||
|
2018
Q3 | $4.71M | Sell |
|
|||||
|
2018
Q2 | $4.53M | Sell |
|
|||||
|
2018
Q1 | $8.08M | Sell |
|
|||||
|
2017
Q4 | $7.49M | Buy |
|
|||||
|
2017
Q3 | $6.31M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $876K | Sell |
|
|||||
|
2016
Q4 | $1.44M | Buy |
|
|||||
|
2016
Q3 | $34K | Sell |
|
|||||
|
2016
Q2 | $5.68M | Buy |
|
|||||
|
2016
Q1 | $1.31M | Buy |
|
|||||
|
2015
Q4 | $1.94M | Buy |
|